IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
UP-0600180
(2003-06-20)
|
등록번호 |
US-7569530
(2009-08-24)
|
발명자
/ 주소 |
- Pan, Robert Ya Lin
- Moese, Rosa Laura
- Saud, Abel
|
출원인 / 주소 |
- The Procter & Gamble Company
|
대리인 / 주소 |
Brinks Hofer Gilson & Lione
|
인용정보 |
피인용 횟수 :
14 인용 특허 :
44 |
초록
▼
Antimicrobial compositions that provide enhanced immediate and residual anti-viral and antibacterial efficacy against rhinovirus, rotavirus, coronovirus, respiratory syncytial virus, Gram-positive bacteria, Gram-negative bacteria and combinations thereof. More specifically, antimicrobial composition
Antimicrobial compositions that provide enhanced immediate and residual anti-viral and antibacterial efficacy against rhinovirus, rotavirus, coronovirus, respiratory syncytial virus, Gram-positive bacteria, Gram-negative bacteria and combinations thereof. More specifically, antimicrobial compositions comprising an organic acid or organic acid mixture and a short-chain anionic surfactant having at least one of a large head group; a branched alkyl chain and an unsaturated alkyl chain. Further, products incorporating the antimicrobial compositions of the present invention and methods of using the antimicrobial compositions and products are disclosed herein.
대표청구항
▼
What is claimed is: 1. An antimicrobial composition capable of inactivating viruses and bacteria consisting of: a. from about 0.2% to about 70% of an organic acid, which is selected from the group consisting of: pyroglutamic acid, adipic acid, gluconic acid, gluconolactone acid, glutamic acid, glut
What is claimed is: 1. An antimicrobial composition capable of inactivating viruses and bacteria consisting of: a. from about 0.2% to about 70% of an organic acid, which is selected from the group consisting of: pyroglutamic acid, adipic acid, gluconic acid, gluconolactone acid, glutamic acid, glutaric acid, glycolic acid, tartaric acid, ascorbic acid, benzoic acid, salicylic acid, citric acid, malic acid, succinic acid, lactic acid and combinations thereof; and b. from about 0.1% to about 40% of an anionic surfactant mixture having a characteristic selected from the group consisting of: i. a linear alkyl chain having a chain length of from about C4 to about C12 and a total hydrophilic head group size of at least about 4 Angstroms; ii. an unsaturated alkyl chain having a chain length of from about C4 to about C12; iii. a branched alkyl chain having a chain length of from about C4 to about C12; and iv. combinations thereof; c. a calcium ion scavenger, which is citric acid, malic acid, succinic acid, or polyacrylic acid; wherein said composition is characterized by a pH of from about 2.0 to about 4.5. 2. The composition of claim 1, wherein said anionic surfactant is selected from the group consisting of: alkyl glyceryl sulfonate, branched alkyl glyceryl sulfonate, alpha sulfo fatty acid, alpha olefin sulfonate, branched alkyl sulfonate, branched alkyl benzene sulfonate, secondary alkyl sulfate, mono ester of alkyl sulfosuccinic acid, alkyl isethionate, alkyl amidosulfonate, branched alkyl phosphonate, branched alkyl phosphate and combinations thereof. 3. The composition of claim 1, further wherein said anionic surfactant is substituted with a substituent selected from the group consisting of: sulfonate, sulfate, phosphonate and combinations thereof. 4. The composition of claim 1 wherein said organic acid is pyroglutamic acid. 5. The composition of claim 1 wherein said organic acid is characterized by a pKa of greater than about 3.0. 6. The composition of claim 1 wherein said calcium ion scavenger is citric acid. 7. The composition of claim 1 wherein said calcium ion scavenger is characterized by a pKa of lower than about 3.0. 8. The composition of claim 1 wherein said calcium ion scavenger is characterized by a calcium ion binding constant log P of greater than about 3.0 at a pH 3. 9. An antimicrobial product comprising the antimicrobial composition of claim 1. 10. The antimicrobial product according to claim 9, wherein said product is a personal care product. 11. The personal care product according to claim 10, wherein said personal care product is selected from the group consisting of: hand soaps, hand sanitizers, body washes, shower gels, shampoos, body lotions, feminine care products, foot care products, deodorants, pet care products and combinations thereof. 12. The antimicrobial product according to claim 9, wherein said product is a household care product. 13. The household care product of claim 12, wherein said product is selected from the group consisting of hard surface cleaners, deodorizers, fabric care compositions, fabric cleaning compositions, manual dish detergents, automatic dish detergents, floor waxes, kitchen cleaners, bathroom cleaners and combinations thereof. 14. The antimicrobial product according to claim 9, wherein said product is selected from the group consisting of: a wipe product suitable for personal care use and household cleaning; a toilet tissue; a towel for hand drying, household drying and household cleaning; a facial tissue; a skin care composition; a first aid or surgical antiseptic; a diaper; a feminine napkin; and combinations thereof. 15. The skin care composition according to claim 14, further comprising a dermatologically acceptable carrier for said antimicrobial composition. 16. A method of killing bacteria, said method comprising the steps of topically applying the composition of claim 1 to an area in need of treatment and, optionally, removing said composition following its application. 17. A method of inactivating viruses, said method comprising the steps of topically applying the composition of claim 1 to an area in need of treatment and, optionally, removing said composition following its application. 18. A method of providing residual antibacterial efficacy, said method comprising the steps of topically applying the composition of claim 1 to an area in need of treatment and, optionally, removing said composition following its application. 19. A method of preventing and/or treating a common cold, respiratory disease and diarrhea in a mammal where said diseases are caused by rhinovirus, rotavirus, coronavirus, respiratory syncytial virus and combinations thereof, said method comprising the steps of topically applying the composition of claim 1 to an area of the mammal in need of treatment and, optionally, removing said composition following its applications. 20. A method of preventing and/or treating bacteria-related diseases in a mammal that result from said mammal's contact with a bacteria-infected substrate, said method comprising the steps of topically applying the composition of claim 1 to an ear of the mammal which is infected with said bacteria and, optionally, removing said composition following its application. 21. A method of reducing inflammation, said method comprising the steps of topically applying the composition of claim 1 to an area in need of treatment, and optionally, removing said composition following its application. 22. The method according to claim 21 wherein said inflammation is caused by a source selected from the group consisting of: plants, diaper rash, insect bites, allergic inflammatory reactions and combinations thereof. 23. A method of preventing inflammation, said method comprising the steps of topically applying the composition of claim 1 to an area for which the prevention of inflammation is desired, and optionally, removing said composition following its application.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.